CD274 and neoplasm: For example, Chunfeng Li et al. (Li et al., 2021) found that low-dose diosbulbin-B (DB) can activate tumour-inherent programmed cell death one ligand 1 (PD-L1)/NLRP3 signalling pathway-mediated inflammatory cell death, thereby increasing cisplatin sensitivity in GC.